Annual Debt To Equity
0.67
-0.02-2.90%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual debt to equity ratio is currently 0.67, with the most recent change of -0.02 (-2.90%) on 31 March 2024. During the last 3 years, it has fallen by -0.23 (-25.56%). TAK annual debt to equity is now -39.64% below its all-time high of 1.11, reached on 31 March 2019.TAK Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
0.73
+0.03+4.29%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly debt to equity ratio is currently 0.73, with the most recent change of +0.03 (+4.29%) on 01 September 2024. Over the past year, it has increased by +0.07 (+10.61%). TAK quarterly debt to equity is now -41.60% below its all-time high of 1.25, reached on 31 December 2018.TAK Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.9% | +10.6% |
| 3 y3 years | -25.6% | -7.6% |
| 5 y5 years | -39.6% | -29.1% |
TAK Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.6% | at low | -11.0% | +10.6% |
| 5 y | 5 years | -39.6% | at low | -32.4% | +10.6% |
| alltime | all time | -39.6% | -41.6% |
Takeda Pharmaceutical Company Limited Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 0.73(+4.3%) |
| June 2024 | - | 0.70(+4.5%) |
| Mar 2024 | 0.67(-2.9%) | 0.67(-2.9%) |
| Dec 2023 | - | 0.69(+4.5%) |
| Sept 2023 | - | 0.66(-4.3%) |
| June 2023 | - | 0.69(0.0%) |
| Mar 2023 | 0.69(-9.2%) | 0.69(0.0%) |
| Dec 2022 | - | 0.69(-2.8%) |
| Sept 2022 | - | 0.71(-2.7%) |
| June 2022 | - | 0.73(-3.9%) |
| Mar 2022 | 0.76(-15.6%) | 0.76(-7.3%) |
| Dec 2021 | - | 0.82(+3.8%) |
| Sept 2021 | - | 0.79(-6.0%) |
| June 2021 | - | 0.84(-6.7%) |
| Mar 2021 | 0.90(-16.7%) | 0.90(-12.6%) |
| Dec 2020 | - | 1.03(-1.9%) |
| Sept 2020 | - | 1.05(-2.8%) |
| June 2020 | - | 1.08(0.0%) |
| Mar 2020 | 1.08(-2.7%) | 1.08(+0.9%) |
| Dec 2019 | - | 1.07(+3.9%) |
| Sept 2019 | - | 1.03(-11.2%) |
| June 2019 | - | 1.16(+4.5%) |
| Mar 2019 | 1.11(+126.5%) | 1.11(-11.2%) |
| Dec 2018 | - | 1.25(+171.7%) |
| Sept 2018 | - | 0.46(-6.1%) |
| June 2018 | - | 0.49(0.0%) |
| Mar 2018 | 0.49(-18.3%) | 0.49(-9.3%) |
| Dec 2017 | - | 0.54(-1.8%) |
| Sept 2017 | - | 0.55(-3.5%) |
| June 2017 | - | 0.57(-5.0%) |
| Mar 2017 | 0.60(+53.8%) | 0.60(+22.4%) |
| Dec 2016 | - | 0.49(-5.8%) |
| Sept 2016 | - | 0.52(-1.9%) |
| June 2016 | - | 0.53(+35.9%) |
| Mar 2016 | 0.39 | 0.39(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | 0.35(+2.9%) |
| Sept 2015 | - | 0.34(0.0%) |
| June 2015 | - | 0.34(0.0%) |
| Mar 2015 | 0.34(-2.9%) | 0.34(-5.6%) |
| Dec 2014 | - | 0.36(0.0%) |
| Sept 2014 | - | 0.36(0.0%) |
| June 2014 | - | 0.36(+2.9%) |
| Mar 2014 | 0.35(+34.6%) | 0.35(+6.1%) |
| Dec 2013 | - | 0.33(-5.7%) |
| Sept 2013 | - | 0.35(+45.8%) |
| June 2013 | - | 0.24(-7.7%) |
| Mar 2013 | 0.26(0.0%) | 0.26(0.0%) |
| Dec 2012 | - | 0.26(-7.1%) |
| Sept 2012 | - | 0.28(-3.4%) |
| June 2012 | - | 0.29(+11.5%) |
| Mar 2012 | 0.26(+2500.0%) | 0.26(-7.1%) |
| Dec 2011 | - | 0.28(-3.4%) |
| Sept 2011 | - | 0.29(>+9900.0%) |
| June 2011 | - | 0.00(-100.0%) |
| Mar 2011 | 0.01(>+9900.0%) | 0.01(>+9900.0%) |
| Dec 2010 | - | 0.00(0.0%) |
| Sept 2010 | - | 0.00(0.0%) |
| June 2010 | - | 0.00(0.0%) |
| Mar 2010 | 0.00(0.0%) | 0.00(0.0%) |
| Dec 2009 | - | 0.00(0.0%) |
| Sept 2009 | - | 0.00(0.0%) |
| Mar 2009 | 0.00(0.0%) | 0.00(0.0%) |
| Dec 2008 | - | 0.00 |
| Mar 2008 | 0.00(0.0%) | - |
| Mar 2007 | 0.00(-100.0%) | - |
| Mar 2006 | 0.01(0.0%) | - |
| Mar 2005 | 0.01(0.0%) | - |
| Mar 2004 | 0.01(0.0%) | - |
| Mar 2003 | 0.01(0.0%) | - |
| Mar 2002 | 0.01(0.0%) | - |
| Mar 2001 | 0.01 | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual debt to equity ratio?
- What is the all time high annual debt to equity for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual debt to equity year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly debt to equity year-on-year change?
What is Takeda Pharmaceutical Company Limited annual debt to equity ratio?
The current annual debt to equity of TAK is 0.67
What is the all time high annual debt to equity for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual debt to equity ratio is 1.11
What is Takeda Pharmaceutical Company Limited annual debt to equity year-on-year change?
Over the past year, TAK annual debt to equity ratio has changed by -0.02 (-2.90%)
What is Takeda Pharmaceutical Company Limited quarterly debt to equity ratio?
The current quarterly debt to equity of TAK is 0.73
What is the all time high quarterly debt to equity for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly debt to equity ratio is 1.25
What is Takeda Pharmaceutical Company Limited quarterly debt to equity year-on-year change?
Over the past year, TAK quarterly debt to equity ratio has changed by +0.07 (+10.61%)